Wnt/β-Catenin Pathway Activation in Mammary Tumors Induced by ATF3
Author Information
Author(s): Yan Leqin, Coletta Luis Della, Powell K. Leslie, Shen Jianjun, Thames Howard, Aldaz C. Marcelo, MacLeod Michael C.
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
The Wnt/β-catenin pathway is activated in mammary tumors induced by the transcription factor ATF3.
Conclusion
The study demonstrates that the Wnt/β-catenin pathway is activated in mammary tumors induced by ATF3, suggesting its role in tumorigenesis.
Supporting Evidence
- β-catenin is overexpressed and localized to the nuclei of tumor cells in BK5.ATF3 tumors.
- Downstream targets of the Wnt/β-catenin pathway are up-regulated in ATF3-induced tumors.
- Wnt ligands are significantly overexpressed in BK5.ATF3 tumors.
- Knockdown of ATF3 decreases expression of Wnt pathway genes.
- ATF3 and JUN proteins bind to AP-1 sites upstream of Wnt target genes.
Takeaway
Mice with a specific gene that makes them produce more of a protein called ATF3 develop breast tumors, and this is linked to a pathway that helps cells grow and divide.
Methodology
The study used transgenic mouse models, immunohistochemistry, and quantitative PCR to analyze gene expression and pathway activation.
Limitations
The study primarily focuses on a specific mouse model, which may not fully represent human breast cancer.
Participant Demographics
Female transgenic mice
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website